Why the study?
Do corticosteroids and/or immunosuppressive therapies reduce relapse rates and major cardiac adverse events in patients with cardiac sarcoidosis?
Do corticosteroids and/or immunosuppressive therapies reduce relapse rates and major cardiac adverse events in patients with cardiac sarcoidosis?
Answers are grounded in this paper and cite their sources.
Corticosteroids appear to have a positive impact on cardiac sarcoidosis, but the lack of randomized trials and unclear benefits of adjunctive immunosuppressive therapies highlight a significant evidence gap.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Helen Bedford (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: